Millions of people worldwide suffer from brain-related issues that can already be addressed with the latest breakthroughs in neurotechnology at-home. We leverage cutting edge research to develop drastically better solutions for the greatest challenges to brain health.
Current solutions fail to achieve satisfactory outcomes: about 25% of 80 million migraineurs in the US and Europe are dissatisfied with existing treatment options. Research indicates that the stimulation protocol we use reduces migraine attacks by over 50%, providing much needed relief to those who need it.
AI powered, personalized Neurotech
Our vision is that Brightmind.AI’s personalized brain stimulation solutions are available in homes worldwide, offering to address globally important challenges to brain health such as pain relief, preventing cognitive decline and treating depression.
The convenience of a Brightmind.AI stimulation headset at home is set out to deliver unparalleled possibilities in personalized treatment of neurological challenges – everyday, at the push of a button.
Closed-loop, non-invasive brain stimulation with the use of transcranial magnetic stimulation and advanced brain monitoring is the most promising technology to effectively optimize neural activity in order for everyone to unlock their full potential.
We are happy to share that our company is in the following valued partnerships and funded by Seedfinancing – Deep Tech of the BWAW / the BMK, handled by the aws and backed by the VC Xista and FFG.
We are pleased to announce the following awards from the press: